BCL2 and hepatocellular carcinoma: Overexpressing IRF2 with AdIRF2 transduction increased the expression of Bcl-2, survivin and 116kDaPARP, which inhibit cellular apoptosis, and promoted the expression of β-catenin in HCC cells (Fig. 2A).